Peptide record

TPDB44871

Antiviral standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB44871
Antiviral
Anti-infective peptides
AI4AVP Peptipedia
standard
No
A 20-aa standard-residue antiviral peptide sequence curated from AI4AVP and Peptipedia, with an available 3D structural model.
Sequence
DLYVGSDLEIGQHRTKIEEL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C101H163N27O35
ANCMFPW
EL
2315.57
4.28
3
5
7
-3
2.21
-0.580
112.00
Mammalian: 1.1 hour Yeast: 3 min E.coli: >10 hour
1490
0.64
4
Residue Composition
number
0
A
1
R
0
N
2
D
0
C
3
E
1
Q
2
G
1
H
2
I
3
L
1
K
0
M
0
F
0
P
1
S
1
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 2 C: 0 E: 3 Q: 1 G: 2 H: 1 I: 2 L: 3 K: 1 M: 0 F: 0 P: 0 S: 1 T: 1 W: 0 Y: 1 V: 1
Chemical Descriptors
20 reviewed residue count
C101H163N27O35 sequence-only estimate (linear, free termini)
2315.57 sequence-only estimate (linear, free termini)
4.28 sequence-only estimate (linear, free termini)
-3 sequence-only estimate (linear, free termini)
2.21 sequence-only estimate (linear, free termini)
-0.580 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA